Invention Grant
- Patent Title: Hydroxyalkyl-substituted triazole derivatives and uses thereof
-
Application No.: US16343150Application Date: 2017-10-16
-
Publication No.: US10927098B2Publication Date: 2021-02-23
- Inventor: Chantal Fuerstner , Marie-Pierre Collin-Kroepelin , Peter Kolkhof , Thomas Neubauer , Elisabeth Pook , Heiko Schirmer , Carsten Schmeck , Pierre Wasnaire , Matthias Beat Wittwer
- Applicant: Bayer Pharma Aktiengesellschaft
- Applicant Address: DE Berlin
- Assignee: Bayer Pharma Aktiengesellschaft
- Current Assignee: Bayer Pharma Aktiengesellschaft
- Current Assignee Address: DE Berlin
- Agency: McBee Moore & Vanik IP, LLC
- Priority: EP16194869 20161020
- International Application: PCT/EP2017/076280 WO 20171016
- International Announcement: WO2018/073144 WO 20180426
- Main IPC: C07D403/06
- IPC: C07D403/06 ; A61P13/12 ; C07D403/14
Abstract:
The present invention relates to novel 3-(hydroxyalkyl)-1,2,4-triazole derivatives, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of renal and/or cardiovascular diseases.
Public/Granted literature
- US20190315720A1 HYDROXYALKYL-SUBSTITUTED TRIAZOLE DERIVATIVES AND USES THEREOF Public/Granted day:2019-10-17
Information query
